Technical Analysis for CRTX - Cortexyme, Inc.

Grade Last Price % Change Price Change
grade B 27.36 -0.47% -0.13
CRTX closed down 0.47 percent on Friday, May 24, 2019, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical CRTX trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Up 3 Days in a Row Strength -0.47%
Up 4 Days in a Row Strength -0.47%
Up 5 Days in a Row Strength -0.47%
Doji - Bearish? Reversal 0.04%
Up 3 Days in a Row Strength 0.04%
Up 4 Days in a Row Strength 0.04%
Up 5 Days in a Row Strength 0.04%
Up 3 Days in a Row Strength 0.15%

Older signals for CRTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Cortexyme is a clinical stage pharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer's disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company's lead investigational medicine, COR388, is the subject of the GAIN Trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s.
Medical Specialties Organ Systems Alzheimer's Disease Nervous System Neurology Degenerative Diseases Stage Pharmaceutical
Is CRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 13 72 Biggest Movers From Friday
May 9 Cortexyme prices IPO at $17
May 8 Cortexyme, Inc. Announces Pricing of Initial Public Offering
May 6 Cortexyme IPO Isn't Cheap
May 4 IPO Outlook For The Week: Uber (And 11 Others)
See more CRTX news...
Indicators
Indicator Value
52 Week High 34.73
52 Week Low 19.5
Average Volume 181,463
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 25.966
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0764
MACD Signal Line 0.0153
MACD Histogram 0.0611
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.59
Resistance 3 (R3) 28.50 27.99 28.39
Resistance 2 (R2) 27.99 27.68 28.04 28.32
Resistance 1 (R1) 27.68 27.49 27.43 27.77 28.25
Pivot Point 27.17 27.17 27.05 27.22 27.17
Support 1 (S1) 26.86 26.86 26.61 26.95 26.47
Support 2 (S2) 26.35 26.67 26.40 26.40
Support 3 (S3) 26.04 26.35 26.34
Support 4 (S4) 26.13